Clinical trials
Recruiting Carcinoma, Non-Small-Cell Lung trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 2 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 8 |
| 2024 | 19 |
| 2025 | 20 |
| 2026 | 8 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 7 |
| Bristol-Myers Squibb | 5 |
| AbbVie | 3 |
| AstraZeneca | 3 |
| Maastricht University Medical Center | 3 |
| Novartis Pharmaceuticals | 3 |
| Pierre Fabre Medicament | 3 |
| Revolution Medicines, Inc. | 3 |
| University Medical Center Groningen | 3 |
| Amgen | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 67 |
| Lung Neoplasms | 22 |
| Neoplasms | 9 |
| Breast Neoplasms | 5 |
| Lung Diseases | 5 |
| Stomach Neoplasms | 5 |
| Bronchial Neoplasms | 4 |
| Carcinoma | 4 |
| Colorectal Neoplasms | 4 |
| Adenocarcinoma | 3 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.